Stay updated on Evorpacept Plus Pembrolizumab in Advanced Head & Neck SCC Clinical Trial
Sign up to get notified when there's something new on the Evorpacept Plus Pembrolizumab in Advanced Head & Neck SCC Clinical Trial page.

Latest updates to the Evorpacept Plus Pembrolizumab in Advanced Head & Neck SCC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAdded a new revision entry for v3.5.2 and removed the v3.5.0 entry in the record history.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedRevision history updated to v3.5.0 and v3.4.3 was removed from the records.SummaryDifference0.1%

- Check46 days agoChange DetectedThe study history now shows the latest revision as v3.4.3, replacing v3.4.2. This change is limited to version labeling and does not modify the study's content or behavior.SummaryDifference0.1%

- Check74 days agoChange DetectedA new revision entry (v3.4.2) was added to the record history, and the prior funding-status notice and revision v3.4.1 were removed.SummaryDifference0.7%

- Check81 days agoChange DetectedA general notice about government funding and the NIH Clinical Center’s operating status has been added to the page. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.7%

- Check88 days agoChange DetectedThe history view now includes a glossary toggle and green/red color-coded highlights to distinguish additions and deletions. Footer notes were updated to show Revision: v3.4.0, with the previous No FEAR Act text and revision (v3.3.4) replaced.SummaryDifference0.9%

Stay in the know with updates to Evorpacept Plus Pembrolizumab in Advanced Head & Neck SCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Evorpacept Plus Pembrolizumab in Advanced Head & Neck SCC Clinical Trial page.